PACB - Pacific Biosciences of California, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5681M
Enterprise Value 3712.02M
Trailing P/E N/A
Forward P/E 1-7.67
PEG Ratio (5 yr expected) 1-0.25
Price/Sales (ttm)7.49
Price/Book (mrq)12.40
Enterprise Value/Revenue 37.83
Enterprise Value/EBITDA 6-7.64

Trading Information

Stock Price History

Beta (5Y Monthly) 1.97
52-Week Change 3-36.35%
S&P500 52-Week Change 321.60%
52 Week High 37.5000
52 Week Low 33.9000
50-Day Moving Average 34.8015
200-Day Moving Average 35.1499

Share Statistics

Avg Vol (3 month) 32.19M
Avg Vol (10 day) 33.28M
Shares Outstanding 5153.03M
Float 149.44M
% Held by Insiders 14.08%
% Held by Institutions 181.91%
Shares Short (Jan 30, 2020) 417.21M
Short Ratio (Jan 30, 2020) 46.36
Short % of Float (Jan 30, 2020) 412.21%
Short % of Shares Outstanding (Jan 30, 2020) 411.25%
Shares Short (prior month Dec 30, 2019) 420.38M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Dec 30, 2019


Profit Margin -92.57%
Operating Margin (ttm)-110.62%

Management Effectiveness

Return on Assets (ttm)-39.49%
Return on Equity (ttm)-99.58%

Income Statement

Revenue (ttm)90.89M
Revenue Per Share (ttm)0.60
Quarterly Revenue Growth (yoy)43.00%
Gross Profit (ttm)34.58M
EBITDA -93.23M
Net Income Avi to Common (ttm)-84.13M
Diluted EPS (ttm)-0.5520
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)49.1M
Total Cash Per Share (mrq)0.32
Total Debt (mrq)61.67M
Total Debt/Equity (mrq)112.30
Current Ratio (mrq)3.71
Book Value Per Share (mrq)0.36

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A